INVITRO ACTIVITY OF HR-810, A NEW CEPHALOSPORIN

被引：39

作者：

BERTRAM, MA ^{[1
]}

BRUCKNER, DA ^{[1
]}

YOUNG, LS ^{[1
]}

机构：

[1] UNIV CALIF LOS ANGELES,MED CTR,DIV INFECT DIS,LOS ANGELES,CA 90024

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1984年 / 26卷 / 02期

关键词：

D O I：

10.1128/AAC.26.2.277

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：277 / 279

页数：3

共 16 条

[1] SUSCEPTIBILITY OF GRAM-POSITIVE AEROBIC COCCI TO THE NEW CEPHALOSPORIN HR-810 [J].

BAUERNFEIND, A .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) :354-355

[2] A COMPARISON OF THE ANTIBACTERIAL ACTIVITIES OF N-FORMIMIDOYL THIENAMYCIN (MK0787) WITH THOSE OF OTHER RECENTLY DEVELOPED BETA-LACTAM DERIVATIVES [J].

CULLMANN, W ;

OPFERKUCH, W ;

STIEGLITZ, M ;

WERKMEISTER, U .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (02) :302-307

[3] RELATION BETWEEN BETA-LACTAMASE PRODUCTION AND ANTI-MICROBIAL ACTIVITY - COMPARISON OF THE NEW COMPOUND HR-810 WITH CEFOTAXIME [J].

CULLMANN, W ;

OPFERKUCH, W ;

STIEGLITZ, M .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) :350-352

[4] COMPARATIVE INVITRO ACTIVITY OF MOXALACTAM, CEFOTAXIME, CEFOPERAZONE, PIPERACILLIN, AND AMINOGLYCOSIDES AGAINST GRAM-NEGATIVE BACILLI [J].

KURTZ, TO ;

WINSTON, DJ ;

HINDLER, JA ;

YOUNG, LS ;

HEWITT, WL ;

MARTIN, WJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (04) :645-648

[5] RANDOMIZED COMPARATIVE-STUDY OF MOXALACTAM AND CEFAZOLIN IN THE TREATMENT OF ACUTE URINARY-TRACT INFECTIONS IN ADULTS [J].

LEA, AS ;

SUDAN, AW ;

WOOD, BA ;

GENTRY, LO .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (01) :32-35

[6]

MACKHA K, 1983, EUR J CLIN MICROBIOL, V2, P345

[7]

NEU HC, 1983, ANN INTERN MED, V98, P415

[8] THE NEW BETA-LACTAMASE-STABLE CEPHALOSPORINS [J].

NEU, HC .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (03) :408-419

[9] COAGULOPATHY ASSOCIATED WITH THE USE OF MOXALACTAM [J].

PAKTER, RL ;

RUSSELL, TR ;

MIELKE, CH ;

WEST, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (09) :1100-1100

[10] MOXALACTAM THERAPY OF INFECTIONS CAUSED BY CEPHALOTHIN-RESISTANT BACTERIA - INFLUENCE OF SERUM INHIBITORY ACTIVITY ON CLINICAL-RESPONSE AND ACQUISITION OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J].

PLATT, R ;

EHRLICH, SL ;

AFARIAN, J ;

OBRIEN, TF ;

PENNINGTON, JE ;

KASS, EH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (03) :351-355

← 1 2 →